| scholarly article | Q13442814 |
| P356 | DOI | 10.1093/RHEUMATOLOGY/KEQ263 |
| P953 | full work available at URL | https://academic.oup.com/rheumatology/article-pdf/50/1/40/5064074/keq263.pdf |
| http://academic.oup.com/rheumatology/article-pdf/50/1/40/5064074/keq263.pdf | ||
| http://rheumatology.oxfordjournals.org/cgi/content/abstract/50/1/40 | ||
| P698 | PubMed publication ID | 20847201 |
| P5875 | ResearchGate publication ID | 46288375 |
| P50 | author | Michael E Weinblatt | Q88922582 |
| Nancy A Shadick | Q91503753 | ||
| Daniel H Solomon | Q91503755 | ||
| Christine K Iannaccone | Q107426514 | ||
| Michelle L Frits | Q107426643 | ||
| P2093 | author name string | Jing Cui | |
| Robert M. Plenge | |||
| Yvonne C. Lee | |||
| Roberta J. Glass | |||
| P2860 | cites work | The Journal of Rheumatology | Q7743623 |
| The relationship between focal erosions and generalized osteoporosis in postmenopausal women with rheumatoid arthritis. | Q37357370 | ||
| Common variants at CD40 and other loci confer risk of rheumatoid arthritis | Q37376871 | ||
| Recent advances in the genetics of rheumatoid arthritis | Q41968850 | ||
| HPLC-based analysis of serum N-glycans on a 96-well plate platform with dedicated database software. | Q46808539 | ||
| Comparison of drug retention rates and causes of drug discontinuation between anti-tumor necrosis factor agents in rheumatoid arthritis | Q47911250 | ||
| Therapeutic efficacy of multiple intravenous infusions of anti-tumor necrosis factor alpha monoclonal antibody combined with low-dose weekly methotrexate in rheumatoid arthritis | Q77341367 | ||
| The benefits of early treatment in rheumatoid arthritis: confounding by indication, and the issue of timing | Q78794804 | ||
| Principal components analysis corrects for stratification in genome-wide association studies | Q27860975 | ||
| A missense single-nucleotide polymorphism in a gene encoding a protein tyrosine phosphatase (PTPN22) is associated with rheumatoid arthritis | Q28267921 | ||
| Hand bone mineral density is associated with both total hip and lumbar spine bone mineral density in post-menopausal women with RA. | Q33646329 | ||
| Therapeutic effect of the combination of etanercept and methotrexate compared with each treatment alone in patients with rheumatoid arthritis: double-blind randomised controlled trial | Q33976382 | ||
| Associations between human leukocyte antigen, PTPN22, CTLA4 genotypes and rheumatoid arthritis phenotypes of autoantibody status, age at diagnosis and erosions in a large cohort study | Q34156559 | ||
| TNFalpha inhibitors may improve asthma symptoms: a case series of 12 patients with rheumatoid arthritis and asthma | Q34198210 | ||
| A broad analysis of IL1 polymorphism and rheumatoid arthritis. | Q34788695 | ||
| The validity of a rheumatoid arthritis medical records-based index of severity compared with the DAS28 | Q34897125 | ||
| Observational research methods. Research design II: cohort, cross sectional, and case-control studies | Q35047744 | ||
| Genetic variants at CD28, PRDM1 and CD2/CD58 are associated with rheumatoid arthritis risk | Q35125868 | ||
| Opposing effects of the D70 mutation and the shared epitope in HLA-DR4 on disease activity and certain disease phenotypes in rheumatoid arthritis. | Q36204157 | ||
| Agreement between patient report and medical record review for medications used for rheumatoid arthritis: the accuracy of self-reported medication information in patient registries. | Q36748229 | ||
| Rheumatoid arthritis risk allele PTPRC is also associated with response to anti-tumor necrosis factor alpha therapy | Q36839197 | ||
| The role of drug and disease registries in rheumatic disease epidemiology | Q37113333 | ||
| Two independent alleles at 6q23 associated with risk of rheumatoid arthritis | Q37120830 | ||
| Genome-wide association study of determinants of anti-cyclic citrullinated peptide antibody titer in adults with rheumatoid arthritis | Q37126187 | ||
| Investigation of candidate polymorphisms and disease activity in rheumatoid arthritis patients on methotrexate | Q37190006 | ||
| European biologicals registers: methodology, selected results and perspectives | Q37224062 | ||
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | rheumatoid arthritis | Q187255 |
| genetic predisposition to disease | Q64843122 | ||
| P304 | page(s) | 40-46 | |
| P577 | publication date | 2010-09-16 | |
| P1433 | published in | Rheumatology | Q7320492 |
| P1476 | title | Using genetic and clinical data to understand response to disease-modifying anti-rheumatic drug therapy: data from the Brigham and Women's Hospital Rheumatoid Arthritis Sequential Study | |
| P478 | volume | 50 |
| Q38842054 | Assessment of Confounders in Comparative Effectiveness Studies From Secondary Databases |
| Q55043697 | Association between inflammation and systolic blood pressure in RA compared to patients without RA. |
| Q48503661 | Association of Low Bone Mineral Density with Anti-Citrullinated Protein Antibody Positivity and Disease Activity in Established Rheumatoid Arthritis: Findings from a US Observational Cohort |
| Q33596873 | Associations of smoking and alcohol consumption with disease activity and functional status in rheumatoid arthritis |
| Q38445673 | Automatic prediction of rheumatoid arthritis disease activity from the electronic medical records |
| Q34154461 | Behavioral and clinical factors associated with self-reported abnormal Papanicolaou tests in rheumatoid arthritis |
| Q38950371 | Cardiovascular disease in patients with rheumatoid arthritis |
| Q28082992 | Cardiovascular disease risk scores in the current practice: which to use in rheumatoid arthritis? |
| Q35558691 | Clinical characteristics of RA patients with secondary SS and association with joint damage |
| Q33568343 | Clinical patient registry recruitment and retention: a survey of patients in two chronic disease registries |
| Q35096891 | Clinical predictors of erosion-free status in rheumatoid arthritis: a prospective cohort study |
| Q35766847 | Detection of Rheumatoid Arthritis-Interstitial Lung Disease Is Enhanced by Serum Biomarkers. |
| Q34667793 | Development of a multi-biomarker disease activity test for rheumatoid arthritis |
| Q36830635 | Do rheumatologists know best? An outcomes study of inconsistent users of disease-modifying anti-rheumatic drugs |
| Q33795738 | Drug safety analyses in a rheumatoid arthritis registry: application of different approaches regarding timing of exposure and confounder measurement |
| Q30984829 | Effects of Achieving Target Measures in Rheumatoid Arthritis on Functional Status, Quality of Life, and Resource Utilization: Analysis of Clinical Practice Data |
| Q50901847 | Fibromyalgia and the Prediction of Two-Year Changes in Functional Status in Rheumatoid Arthritis Patients |
| Q33829662 | Functional impact of a spectrum of interstitial lung abnormalities in rheumatoid arthritis |
| Q90610899 | Genetic associations with radiological damage in rheumatoid arthritis: Meta-analysis of seven genome-wide association studies of 2,775 cases |
| Q88419825 | Impact of Changes in Inflammation on Estimated Ten-Year Cardiovascular Risk in Rheumatoid Arthritis |
| Q30860792 | Inconsistent treatment with disease-modifying antirheumatic drugs: a longitudinal data analysis |
| Q64269703 | Interference of tumor necrosis factor inhibitor treatments on soluble tumor necrosis factor receptor 2 levels in rheumatoid arthritis |
| Q36696967 | Multibiomarker disease activity score and C-reactive protein in a cross-sectional observational study of patients with rheumatoid arthritis with and without concomitant fibromyalgia |
| Q38178003 | Multimorbidity and rheumatic conditions-enhancing the concept of comorbidity |
| Q34031181 | PTPN22.6, a dominant negative isoform of PTPN22 and potential biomarker of rheumatoid arthritis |
| Q35557868 | Pain persists in DAS28 rheumatoid arthritis remission but not in ACR/EULAR remission: a longitudinal observational study |
| Q30488431 | Participation in Clinical Research Registries: A Focus Group Study Examining Views From Patients With Arthritis and Other Chronic Illnesses. |
| Q36674075 | Performance of matrix-based risk models for rapid radiographic progression in a cohort of patients with established rheumatoid arthritis |
| Q38195630 | Pharmacogenetics and pharmacogenomics for rheumatoid arthritis responsiveness to methotrexate treatment: the 2013 update |
| Q38084444 | Pharmacogenetics of disease-modifying antirheumatic drugs in rheumatoid arthritis: towards personalized medicine |
| Q28068930 | Pharmacogenomics in Pediatric Oncology: Review of Gene-Drug Associations for Clinical Use |
| Q47874353 | Physical Activity and Correlates of Physical Activity Participation Over Three Years in Adults With Rheumatoid Arthritis |
| Q33747444 | Prediction of methotrexate clinical response in Portuguese rheumatoid arthritis patients: implication of MTHFR rs1801133 and ATIC rs4673993 polymorphisms |
| Q64101224 | Prevalence and predictors for sustained remission in rheumatoid arthritis |
| Q60918012 | Probabilistic record linkage of de-identified research datasets with discrepancies using diagnosis codes |
| Q38621658 | Rationale and Design of the Brigham Cohort for psoriasis and psoriatic arthritis registry (COPPAR) |
| Q33953283 | Rheumatoid arthritis quality measures and radiographic progression |
| Q34301896 | Subgrouping of patients with rheumatoid arthritis based on pain, fatigue, inflammation, and psychosocial factors |
| Q36245761 | Sustained rheumatoid arthritis remission is uncommon in clinical practice |
| Q92224133 | The Impact of Exercise, Lifestyle, and Clinical Factors on Perceived Cognitive Function in Patients with Rheumatoid Arthritis: Results from a Prospective Cohort Study |
| Q35135726 | The association between reduction in inflammation and changes in lipoprotein levels and HDL cholesterol efflux capacity in rheumatoid arthritis |
| Q40748946 | The impact of multimorbidity status on treatment response in rheumatoid arthritis patients initiating disease-modifying anti-rheumatic drugs |
| Q36464352 | Traditional cardiovascular risk factors, inflammation and cardiovascular risk in rheumatoid arthritis |
| Q30678187 | Use of data from multiple registries in studying biologic discontinuation: challenges and opportunities |
| Q36428250 | Validation of a novel multibiomarker test to assess rheumatoid arthritis disease activity |
| Q33749962 | Validity of the Nurses' health study physical activity questionnaire in estimating physical activity in adults with rheumatoid arthritis |
| Q52862596 | [Biomarkers for prognosis of response to anti-TNF therapy of rheumatoid arthritis: Where do we stand?]. |
Search more.